Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chantal Roth"'
Publikováno v:
Symmetry, Vol 15, Iss 9, p 1672 (2023)
We present a quaternion representation of quantum mechanics that allows its ontological interpretation. The correspondence between classical and quaternion quantum equations permits one to consider the universe (vacuum) as an ideal elastic solid. Ele
Externí odkaz:
https://doaj.org/article/4c27a865dffd40f8893a03197faf7c0e
Autor:
Erik J van Helden, Otto S Hoekstra, Ronald Boellaard, Chantal Roth, Emma R Mulder, Henk M W Verheul, C Willemien Menke-van der Houven van Oordt
Publikováno v:
PLoS ONE, Vol 11, Iss 5, p e0155178 (2016)
OBJECTIVE:The aim of this pilot study was to explore intrapatient mixed metabolic response and early 18F-FDG PET response evaluation using predefined quantification strategies in patients with advanced KRAS wild-type colorectal adenocarcinoma (mCRC)
Externí odkaz:
https://doaj.org/article/49091125a27f4fd896e56f6e516d9af6
Autor:
Erin Hanson, Guro Dørum, Manuel Zamborlin, Shouyu Wang, Mario Gysi, Sabrina Ingold, Robert Lagace, Chantal Roth, Cordula Haas, Jack Ballantyne
Publikováno v:
International journal of legal medicine.
The evidentiary value of DNA profiles varies depending upon the context in which the DNA was found. Linking a DNA profile to a particular cellular phenotype in mixtures may aid in assessing its evidentiary relevance and value. We report the developme
Autor:
Leonor Gusmão, Bruce Budowle, Carlos Vullo, Jennifer Churchill Cihlar, Reinhard Würzner, Seah Lay Hong, Claudia Barletta-Carrillo, Wiliam Usaquén, Bettina Zimmermann, Rosane Silva, Chantal Roth, Martin Bodner, Harald Niederstätter, Rodrigo S. Moura-Neto, L. Souto, Gabriela Huber, Robert Lagacé, Dayse A. Silva, Christina Strobl, Balázs Egyed, Walther Parson, Dean Herman Tineo, Andrea Casas-Vargas, Catarina Xavier, Katja Anslinger, Farida Alshamali, Lisa Schnaller, Sharon Wootton, Renata Jankova-Ajanovska, Nicole Huber
Publikováno v:
Forensic Science International: Genetics. 42:244-251
The emergence of Massively Parallel Sequencing technologies enabled the analysis of full mitochondrial (mt)DNA sequences from forensically relevant samples that have, so far, only been typed in the control region or its hypervariable segments. In thi
Publikováno v:
Australian Journal of Forensic Sciences. 51:S52-S55
Mitochondrial DNA (mtDNA) sequencing is a valuable forensics tool in determining the source of DNA obtained from degraded, damaged or small biological samples. However, despite the recent a...
Autor:
Weena J Y, Chen, Yvonne H M, Krul-Poel, Chantal, Roth, Mariette, Labots, Alfons J M, van den Eertwegh, Koen M A, Dreijerink
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 163
Checkpoint inhibition has emerged as a promising therapeutic strategy for several types of cancer. Immune-related adverse effects (irAEs) commonly involve the endocrine system. Distinguishing endocrine side effect-related symptoms from disease progre
Autor:
Christina Amory, Robert Lagacé, Jennifer Churchill Cihlar, Bruce Budowle, Walther Parson, Chantal Roth
Publikováno v:
Genes
Volume 11
Issue 11
Genes, Vol 11, Iss 1345, p 1345 (2020)
Volume 11
Issue 11
Genes, Vol 11, Iss 1345, p 1345 (2020)
For the adoption of massively parallel sequencing (MPS) systems by forensic laboratories, validation studies on specific workflows are needed to support the feasibility of implementation and the reliability of the data they produce. As such, the whol
Autor:
Anne Marije Luik, E. Mulder, Elske C. Gootjes, Marc C. Huisman, Catherina Willemien Menke-van der Houven, Danielle J. Vugts, Guus A.M.S. van Dongen, Chantal Roth, Henk M.W. Verheul, Robert C. Schuit, Otto S. Hoekstra, Ronald Boellaard
Publikováno v:
van der Houven van Oordt, C W, Gootjes, E C, Huisman, M C, Vugts, D J, Roth, C, Luik, A M, Mulder, E R, Schuit, R C, Boellaard, R, Hoekstra, O S, van Dongen, G A M S & Verheul, H M W 2015, ' Zr-89-cetuximab PET imaging in patients with advanced colorectal cancer ', Oncotarget, vol. 6, no. 30, pp. 30384-30393 . https://doi.org/10.18632/oncotarget.4672
Oncotarget
Oncotarget, 6(30), 30384-30393. Impact Journals
Oncotarget
Oncotarget, 6(30), 30384-30393. Impact Journals
Monoclonal antibodies (mAbs) against the epidermal growth factor receptor (EGFR) are used in the treatment of advanced colorectal cancer (mCRC). Approximately 50% of patients benefit despite patient selection for RAS wild type (wt) tumors. Based on t
Autor:
E. Mulder, Chantal Roth, Henk M.W. Verheul, Erik J van Helden, C. Willemien Menke-van der Houven van Oordt, Otto S. Hoekstra, Ronald Boellaard
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 5, p e0155178 (2016)
van Helden, E J, Hoekstra, O S, Boellaard, R, Roth, C, Mulder, E R, Verheul, H M W & Menke-van der Houven van Oordt, C 2016, ' Early F-18-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer ', PLoS ONE, vol. 11, no. 5, e0155178 . https://doi.org/10.1371/journal.pone.0155178
PLoS ONE, 11(5):e0155178. Public Library of Science
PLoS ONE, Vol 11, Iss 5, p e0155178 (2016)
van Helden, E J, Hoekstra, O S, Boellaard, R, Roth, C, Mulder, E R, Verheul, H M W & Menke-van der Houven van Oordt, C 2016, ' Early F-18-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer ', PLoS ONE, vol. 11, no. 5, e0155178 . https://doi.org/10.1371/journal.pone.0155178
PLoS ONE, 11(5):e0155178. Public Library of Science
OBJECTIVE:The aim of this pilot study was to explore intrapatient mixed metabolic response and early 18F-FDG PET response evaluation using predefined quantification strategies in patients with advanced KRAS wild-type colorectal adenocarcinoma (mCRC)
Autor:
Nicole C.T. van Grieken, Ronald Boellaard, Robert C. Schuit, G.A.M.S. (Guus) van Dongen, Elske C. Gootjes, Chantal Roth, Otto S. Hoekstra, Henk M.W. Verheul, E. Mulder, Catharina Wilhelmina Menke, Danielle J. Vugts, Marc C. Huisman
Publikováno v:
Journal of Clinical Oncology. 32:11102-11102
11102 Background: Inhibition of epidermal growth factor receptor (EGFR) with cetuximab is part of treatment for patients with wild type (wt) KRAS advanced colorectal cancer (mCRC). Sixty percent of...